Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Latcha S, Jaimes EA, Gutgarts V, Seshan S. Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and Gefitinib. Kidney Int Rep. 2018;3(6):1477-1481.

van Rhee F, Voorhees P, Dispenzieri A, Fossa A, Srkalovic G, Ide M, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115-2124.

Castellino A, Chiappella A, LaPlant BR, Pederson LD, Gaidano G, Macon WR, et al. Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials. Blood Cancer J. 2018;8(11):108.

DeSimone RA, Leung WK, Schwartz J. Transfusion Medicine in a Multidisciplinary Approach to Morbidly Adherent Placenta: Preparing for and Preventing the Worst. Transfus Med Rev. 2018;32(4):244-248.

Jain M, Robinson BD, Wu B, Khani F, Mukherjee S. Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections. Arch Pathol Lab Med. 2018;142(3):383-390.

Schäffner I, Minakaki G, M Khan A, Balta E-, Schlötzer-Schrehardt U, Schwarz TJ, et al. FoxO Function Is Essential for Maintenance of Autophagic Flux and Neuronal Morphogenesis in Adult Neurogenesis. Neuron. 2018;99(6):1188-1203.e6.

Wang Z, Cao S, Morris JS, Ahn J, Liu R, Tyekucheva S, et al. Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration. iScience. 2018;9:451-460.

Tabbo F, Nottegar A, Guerrera F, Migliore E, Luchini C, Maletta F, et al. Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma. Hum Pathol. 2018;75:167-178.

Zhang Y, Mun SR, Linares JF, Ahn JW, Towers CG, Ji CH, et al. ZZ-dependent regulation of p62/SQSTM1 in autophagy. Nat Commun. 2018;9(1):4373.

D'Alfonso TM, Subramaniyam S, Ginter PS, Mosquera JM, Croyle J, Liu Y-, et al. Characterization of CD34-deficient myofibroblastomas of the breast. Breast J. 2018;24(1):55-61.